期刊文献+

老年高血压患者左室肥厚及估算肾小球滤过率5年随访

Five-Year Follow-Up Data for Left Ventricular Hypertrophy and Estimated Glomerular Filtration Rate in Older Hypertensive Patients
下载PDF
导出
摘要 目的:研究老年高血压患者治疗过程中左室肥厚(LVH)及估算肾小球滤过率(eGFR)5年间的变化情况。方法:选择在本科住院病史资料完整并随访5年及以上的老年高血压患者为研究对象,自2004年1月起在本科住院的老年高血压患者入院后均计算体质量指数,测血压、血糖、血脂、血肌酐、血尿酸、糖化血红蛋白、尿白蛋白/肌酐比值、肾小球滤过率、心电图及心脏彩超等。依尿白蛋白/肌酐比值、肾小球滤过率为指标将患者分为慢性肾脏病(CKD)组及非慢性肾脏病(NCKD)组。住院期间均选择以坎地沙坦为主的降压治疗措施,长期坚持上述方案治疗使病情控制达标,定期复查并随访5年以上;比较2组患者同一时间点相关指标,组内同一指标按不同随访时间进行比较。结果:2组间比较,各相同时间点对应的收缩压及舒张压差异无统计学意义,而左室质量指数(LVMI)、LVH及eGFR差异有统计学意义。同组内与基线水平比较,CKD组各时间点的收缩压、舒张压、LVMI、LVH及eGFR均明显改善,差异有统计学意义;NCKD组内除eGFR的变化无统计学意义外,其他指标变化情况与CKD组类似。结论:老年高血压患者中CKD及LVH的发生率较高。合理治疗能逆转LVH,保护肾功能。 Objective: To study changes of left ventricular hypertrophy (LVH) and estimated glomerular filtration rate (eGFR) in the process of therapy (5-year follow-up) in the elderly patients with hypertension. Methods:The elderly patients with hypertension, with full medical history and more than five-year follow-up, were included in this study. Values of body mass index (BMI), blood pressure, blood sugar, blood fat, blood creatinine, uric acid, glycosylated hemoglobin, urinary albumin/ereatinine ratio, glomerular filtration rate, electrocardiogram and echocardiography were detected in patients admitted to hospital. Patients were divided into chronic kidney disease (CKD) group and non-CKD (NCKD) group according to urinary albumin/ereatinine ratio and glomerular filtration rate. The candesartan-based antihypertensive treatment was selected to control blood pressure. Patients were followed up for more than 5 years. The related indexes were compared at the same time points between groups. Results: There were no significant differences in systolic blood pressure and diastolic blood pressure in the same time points between two groups. There were significant differences in LVMI, LVH and eGFR. Values of systolic blood pressure, diastolic blood pressure, LVMI, LVH and eGFR were significantly improved after treatment compared with those of baseline levels in CKD group. There was no significant difference in clinical indicators in NCKD group except for eG- FR. Conclusion: The incidence of LVH and CKD were higher in elderly hypertensive patients. By means of reasonable treatment, LVH can be reversed and the renal function was protected.
出处 《天津医药》 CAS 北大核心 2012年第5期452-455,共4页 Tianjin Medical Journal
关键词 高血压 肥大 左心室 肾小球滤过率 肾疾病 随访研究 老年人 hypertension hypertrophy, left ventricular glomerular filtration rate kidney diseases follow-up studies aged
  • 相关文献

参考文献15

  • 1Meinizter A, Seelhorst U, Wellnitz B, et al. Asymmetrical dimethyl- arginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease[J]. Clin Chem ,2007,53(2):273-283.
  • 2Zoccali C, Bode-Boger S, Mallamaci F, et al. Plasma concentrations of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study[J]. Lancet ,2001,358 (11):2113-2117.
  • 3Diep QN,EI Mabronk M,Cohn JS,et al. Structure, endothelial func- tion, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisomeproliferator-activated receptor- gamma[J].Circulation, 2002, 105(19):2296-2302.
  • 4Chen MF, Xie XM, Yang TL,et al. Role of asymmetric dimethylargi- nine in inflammatory reactions by angiotensin II[J]. J Vasc Res, 2007,44(5):391-402.
  • 5Zhang H, Jiang Z, Chang J, et al. Role of NAD(P)H oxidase in trans- forming growth fator-betal-induced monocyte chemoattractant pro- tein-1 and interleukin-6 expression in rat renal tunular epithelial cells[J].Nephrology(Carhon),2009,14(3):302-310.
  • 6Ueda S, Yamagishi S, Matsumoto Y, et al. Involvement of asymmetri- cal dimethylarginine in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease[J]. Life Sci, 2009,84(23): 853-856.
  • 7Palm F, Onozato ML, Luo Z,et al. Dimethylarginine dimethylamino-hydrolase (DDAH): expression, regulation, and function in the car- diovascular and renal systems[J]. Am J Physiol Heart Circ Physiol, 2007,293(6):H3227-3245.
  • 8Amann K, Ritz E, Wiest G, et al. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia[J].J Am Soc Nephrol, 1994,4(10):1814-1819.
  • 9Chen MF, Li YJ, Yang TL, et al. Losartan inhibits monocytic adhe- sion induced by ADMA via downregulation of chemokine receptors in monocytes[J].Eur J Clin Pharmacol,2009,65(5):457-464.
  • 10Paiva H, Laakso J, Lehtimaki T,et al. Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide syn- thase inhibitors[J].J Cardiovasc Pharmacol,2003,41(2):219-222.

二级参考文献9

  • 1邱冬,段勇,王玉明.Cystatin C的测定及临床意义[J].医学综述,2005,11(6):544-547. 被引量:5
  • 2童坦君,张宗玉.泌尿系统生理性衰老[M].医学老年学.第2版.北京:人民卫生出版社,2006:29-31.
  • 3蹇在金.老化检测的指标.现代老年医学精要[M].长沙:湖南科技出版社,1999:60-63.
  • 4Mzoughi S,Albano L,Criste M,et al. Two-year results of renal transplantation in kidney recipients from > or = 65 -year-old deceased donors: a French region experience [J]. Transplant Proc, 2007,39(8) : 2576-2577.
  • 5Bosch JP,Saccaggi A,Lauer A,et al.Renal function reserve in humans:effect of protein intake on glomerular filtration rate.Am J Med,1983,75:943-950
  • 6Juncos L,Cornejo JC,Pamies-Andren E,et al.Renal response to amino acid infusion in essential hypertension.Hypertension,1994,23(Suppl Ⅰ):1225-1230
  • 7Birkenhager WH,Del-Leeuw PW.Non-peptide angiotensin type 1receptor antagonists in the treatment of hypertension[J].J Hypertens,1999,17(7):873-881
  • 8Rosenberg ME,Cbmielewski DH,Hostetter TH.Effect of dietary protein on rat rennin and angiotensionogen gene expression.J Clin Invest,1990,85:1144-1149
  • 9Tietze IN,Sorensen SS,Ivarsen PR,et al.Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment[J].J Hypertens,1997,15(5):551-560

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部